Management of Early-Onset Type 2 Diabetes in Adults
Summary: A 2025 review in the Diabetes & Metabolism Journal explores strategies for managing early-onset type 2 diabetes (EOT2D) in adults. The article emphasizes the importance of early intervention, weight reduction, and preserving β-cell function to delay complications and improve long-term outcomes.
Key Highlights:
- Weight reduction: Lifestyle modification, structured dietary plans, and when appropriate, pharmacologic or surgical interventions are recommended to achieve sustained weight loss.
- Preserving β-cell function: Early initiation of therapies that reduce β-cell stress and maintain tight glycemic control helps slow disease progression.
- Therapeutic escalation: Clinicians are encouraged to move beyond metformin monotherapy sooner when patients are not meeting glycemic targets, incorporating newer agents with cardiovascular and renal benefits.
- Risk stratification: Assess patients based on age at onset, baseline insulin resistance, comorbidities, and family history to guide individualized management.
- Monitoring complications: Early screening for retinopathy, nephropathy, and cardiovascular disease is advised from diagnosis, alongside aggressive risk-factor management.
Read the full review in Diabetes & Metabolism Journal
Keywords:
early-onset type 2 diabetes,
weight reduction,
β-cell preservation,
therapeutic escalation,
cardiovascular risk,
diabetes complications